Skip to main content
. 2017 Jan 21;16:106–114. doi: 10.1016/j.ebiom.2017.01.027

Fig. 1.

Fig. 1

Flow chart of the study.

DLBCL: diffuse large B-cell lymphoma; R-CHOP: rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; CR: complete remission.